Baillie Gifford & Co
QDEL icon

Baillie Gifford & Co’s QuidelOrtho QDEL Stock Holding History

Baillie Gifford & Co’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-128
Closed -$11.4K – 407
2023
Q1 		$11.4K Hold
128
– – ﹤0.01% 388
2022
Q4 		$11K Hold
128
– – ﹤0.01% 408
2022
Q3 		$9K Hold
128
– – ﹤0.01% 417
2022
Q2 		$12K Hold
128
– – ﹤0.01% 397
2022
Q1 		$14K Hold
128
– – ﹤0.01% 411
2021
Q4 		$17K Hold
128
– – ﹤0.01% 400
2021
Q3 		$18K Hold
128
– – ﹤0.01% 383
2021
Q2 		$16K Hold
128
– – ﹤0.01% 378
2021
Q1 		$16K Buy
128
+12
+10% +$2.22K ﹤0.01% 360
2020
Q4 		$21K Buy
+116
New +$25.8K ﹤0.01% 318

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Baillie Gifford & Co's QDEL Position: Q2 2023 in Review

Baillie Gifford & Co sold out of QuidelOrtho (QDEL) in Q2 2023, closing a stake of 128 shares — an estimated $11.4K sold.

Baillie Gifford & Co first reported a position in QDEL in Q4 2020 and held it in 10 quarters. The position peaked at $21K in Q4 2020. 313 funds tracked by Wall St. Rank hold QDEL as of Q2 2023.

  • Baillie Gifford & Co reported no remaining QuidelOrtho position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 128 QuidelOrtho shares in Q2 2023, an estimated $11.4K.
  • Baillie Gifford & Co first reported a position in QuidelOrtho in Q4 2020 and held it in 10 quarters.
  • Baillie Gifford & Co's QuidelOrtho position peaked at $21K in Q4 2020.
  • 313 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.